Form 4: Procter & Gamble Executive Jennifer L. Davis Reports Stock Sale to Cover Taxes
SEC Form 4 Filing
Jennifer L. Davis, CEO Health Care at Procter & Gamble, reported the sale of shares to cover taxes on a stock award, along with holdings of common stock and restricted stock units.
Summary
- On August 20, 2024, Jennifer L. Davis, CEO Health Care at Procter & Gamble, reported a transaction involving Procter & Gamble common stock.
- Davis sold 6,223 shares of common stock at a price of $169.219 per share to cover taxes on a stock award.
- Following the transaction, Davis directly owns 57,319.0851 shares of Procter & Gamble common stock.
- Davis also indirectly owns 14,498.0702 shares through a retirement plan trustee.
- Additionally, Davis holds 136.0431 Restricted Stock Units (RSUs) which will deliver in shares upon retirement.
- On August 15, 2024, Davis was awarded 16.9625 Restricted Stock Units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Future Outlook
The Restricted Stock Units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine sale of shares by an executive.
Key Dates
| Date | Description |
|---|---|
| 08/15/2024 | Date of Restricted Stock Units award |
| 08/20/2024 | Date of stock sale transaction |
| 08/22/2024 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.